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e-mail addresses: joportelinha@gmail.com (J. Portelinha), picoto.maria@gmail.com (M.P. Passarinho), costa.joao@mail.telepac.pt (J.M. Costa).Joana Portelinha ⇑, Maria Picoto Passarinho, João Marques CostaAbstractFacial nerve palsy is associated with significant morbidity and can have different etiologies. The most common causes are Bell’s
palsy, Ramsay–Hunt syndrome and trauma, including surgical trauma. Incidence varies between 17 and 35 cases per 100,000. Initial
evaluation should include accurate clinical history, followed by a comprehensive investigation of the head and neck, including oph-
thalmological, otological, oral and neurological examination, to exclude secondary causes. Routine laboratory testing and diag-
nostic imaging is not indicated in patients with new-onset Bell’s palsy, but should be performed in patients with risk factors,
atypical cases or in any case without resolution within 4 months. Many factors are involved in determining the appropriate treat-
ment of these patients: the underlying cause, expected duration of nerve dysfunction, anatomical manifestations, severity of symp-
toms and objective clinical findings. Systemic steroids should be offered to patients with new-onset Bell’s palsy to increase the
chance of facial nerve recovery and reduce synkinesis. Ophthalmologists play a pivotal role in the multidisciplinary team involved
in the evaluation and rehabilitation of these patients. In the acute phase, the main priority should be to ensure adequate corneal
protection. Treatment depends on the degree of nerve lesion and on the risk of the corneal damage based on the amount of lag-
ophthalmos, the quality of Bell’s phenomenon, the presence or absence of corneal sensitivity and the degree of lid retraction. The
main therapy is intensive lubrication. Other treatments include: taping the eyelid overnight, botulinum toxin injection, tarsorrha-
phy, eyelid weight implants, scleral contact lenses and palpebral spring. Once the cornea is protected, longer term planning for
eyelid and facial rehabilitation may take place. Spontaneous complete recovery of Bell’s palsy occurs in up to 70% of cases. Long-
term complications include aberrant regeneration with synkinesis. FNP after acoustic neuroma surgery remains the most common
indication for FN rehabilitation.
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Facial nerve palsy (FNP) can have many different causes. It
spans across all races and ages and has significant functional,
psychological and social consequences.
Appropriate management is complicated by the wide
spectrum of clinical presentation and disease severity. This
article reviews the anatomy, the main causes and discusses
acute management as well as the long-term options forlong-standing FNP. The ophthalmologist plays a pivotal role
in the multi-disciplinary team involved in the evaluation and
rehabilitation of these patients.
Anatomy
The facial nerve (FN) may become dysfunctional anywhere
along its course. The knowledge of its anatomy and origin of
its branches may help the clinicians to localize the lesion.e:
al.com
40 J. Portelinha et al.It is both a motor and sensory nerve with 3 nuclei:
(1) The main motor nucleus controls the muscles of facial
expression. It lies deep in the lower part of the pons.
Voluntary facial movements originate in the precentral
gyrus. White matter tracts pass through the internal
capsule and cerebral peduncles along with other corti-
cobulbar fibers. The portion of the nucleus that sup-
plies the muscles of the upper part of the face
receives corticonuclear fibers from both cerebral hemi-
spheres and that of the lower half of the face receives
fibres only from the contralateral cortex. Therefore,
with a lesion involving the upper motor neurons, only
the contralateral lower part of the face will be para-
lyzed (central palsy). However, with a lesion of the main
motor nucleus or FN itself (lower motor neuron lesion),
all the affected ipsilateral side will be paralyzed (periph-
eral palsy). Another separate involuntary pathway exists
(extrapyramidal pathways) controlling mimetic or emo-
tional changes in facial expression and is largely
responsible for involuntary blinking.
(2) The parasympathetic nuclei are the superior salivatory
nucleus, which sends fibers for salivary secretion and
the lacrimal nucleus, which supplies the lacrimal gland.
It receives afferent fibers from the hypothalamus for
emotional responses and from the trigeminal sensory
nuclei for reflex lacrimation secondary to irritation of
the cornea and conjunctiva.
(3) The sensory nucleus receives taste fibers from the ante-
rior two-thirds of the tongue.
The FN has both a motor root and a sensory/parasympa-
thetic root (the intermediate nerve). They emerge between
the pons and the medulla oblongata. They pass laterally in
the posterior cranial fossa and in the cerebellopontine angle,
with the vestibulocochlear nerve, and enter the internal
acoustic meatus of the temporal bone, where it traverses
the fallopian canal. The fallopian canal has 3 portions: the lab-
yrinthine, the tympanic and the mastoidal. The geniculate
ganglion is located between the labyrinthine and the tym-
panic portion. It is an important anatomical landmark since
the great superficial petrosal nerve (responsible for lacrimal
secretion) and the small petrosal nerve (which carries secre-
tory fibers to the parotid gland) emerge from it. Therefore,
FN lesions above the geniculate ganglion classically cause
more severe ophthalmic symptoms because lacrimal secre-
tion and orbicularis closure are involved. On the other hand,
the nerve to the stapedius muscle and the chorda tympani
(responsible for taste sensation from the anterior two-thirds
of the tongue and salivary secretion) branch out at the mas-
toid segment. The main branch of the FN exists through
the stylomastoid foramen. It runs through the parotid gland
to innervate the facial musculature through five terminal
branches: temporal, zygomatic, buccal, mandibular and
cervical.Epidemiology
Incidence of FNP varies between 17 and 35 cases per
100,000.1,2 There is no sexual preponderance.1
The incidence in neonates varies from 0.6 to 1.8 per 1000
live births, 91% due to forceps delivery.1Bell’s palsy (BP) is the most common disorder and affects
11–40 persons per 100,000 each year, with peak incidence
between 15 and 50 years old.3 In pregnancy, especially dur-
ing the third trimester and early postpartum, there is a 3-
times greater incidence.1,3
Ramsay–Hunt syndrome (RHS), one main cause of FNP,
presents in only 0.2% of all Varicella Zoster Virus (VZV) cases.4Etiology (Table 1)
Etiology of FNP varies according to the published series.
As reported by Rahman (2007), the most common causes
include BP (51%), trauma (22%) and RHS (7%).1 Peitersen
(2002) found 38 different etiologies of peripheral FNP
(1701 cases of BP, 116 RHS, 76 diabetic, 46 pregnant and
169 neonates).5 According to Hohman (2014), BP accounted
for 38% of cases, acoustic neuroma resections 10%, cancer
7%, iatrogenic injuries 7%, RHS 7%, benign lesions 5%, con-
genital palsy 5%, Lyme disease 4%, and other causes 17%.6
One analysis of 40 pediatric patients with peripheral FNP
found 65% of BP, 37.5% infection, 2.5% tumor lesion and
2.5% suspected chemotherapy toxicity.7
FNP can occur with supranuclear, nuclear or infranuclear
lesions and may be grouped into idiopathic (1), infectious
(2), traumatic (3) and neoplastic (4) (Table 1).8,9
Supranuclear lesions may be caused by a lesion in the
motor cortex, the subcortex or corticobulbar tracts. Com-
monly, the etiology is vascular, but may be demyelinating
or tumoral.
Lower motor neuron lesions can be categorized
anatomically10:
(1) Nuclear: Tumoral, inflammatory or ischemic pathology.
It is usually associated with ipsilateral 6th nerve palsy
and may also affect the descending corticospinal tracts
causing contralateral limb weakness (Millard–Gubler
syndrome).
(2) Cerebellopontine angle: Its contents include the CN V
superiorly, the CN IX and X inferiorly and the CN VII
and VIII in between. One of the first signs of this syn-
drome is the loss of corneal reflex on the ipsilateral
side. Usually caused by an acoustic neuroma, it can also
be caused by meningiomas, metastases, cholesteato-
mas or aneurysms. It is suspected in the case of impair-
ment associated with CN VIII (deafness, vertigo,
hyperacusis, tinnitus).
(3) Facial canal: The proximal part of the canal is particu-
larly prone to ischemia and compression. BP, fractures
of the temporal bone, malignant otitis externa or sup-
purative otitis media, RHS and neoplastic processes
can affect the FN here.
(4) Parotid: A parotid mass with FNP is in general malig-
nant. Other etiologies include inflammatory parotitis




BP is an acute paralysis of one side of the face of unknown
etiology, which remains a diagnosis of exclusion.11
Table 1. Etiologies of facial nerve palsy.
Etiology
Idiopathic Bell’s palsy
Infectious Ramsay–Hunt Syndrome (Varicella Zoster Virus), Lyme disease, tuberculous chronic middle ear infections, dengue fever,
leprosy, mumps, Epstein–Barr virus, cytomegalovirus, HIV, HTLV-1, polio, tetanus and diphtheria
Traumatic/
iatrogenic
Fractures of the temporal bone, post surgery of tumours in the cerebellopontine angle, oral and maxillofacial surgical
procedures, otologic procedures, cosmetic procedures and forceps delivery
Neoplastic/
infiltrative
Acoustic neuroma, parotid tumors, facial nerve schwannomas, malignant tumors of the external meatus, nasopharyngeal
carcinomas, lymphomas. Sarcoidosis, leukemia, collagenosis and amyloidosis
Miscellaneous Neurologic causes: Multiple sclerosis, myasthenia gravis, Guillan–Barre syndrome, hereditary hypertrophic neuropathy,
Melkersson–Rosenthal syndrome, Moebius syndrome, cerebrovascular accident
Systemic/metabolic causes: Diabetes Mellitus, hyperthyroidism, hypertension, pregnancy, acute porphyria, carbon monoxide
toxicity, vitamin A deficiency, ethylene glycol ingestion
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ganglion is thought as the major cause of BP. Murakami iso-
lated HSV-1 DNA from the endoneurial fluid of the FN by
PCR during the acute phase of BP.12 Histopathology shows
the entire FN infiltrated by inflammatory cells, with edema,
axonal changes and myelin breakdown suggesting viral
neuritis.1
Another etiology has been postulated: perineural edema
from retention of fluid and mechanical compression within
the bony course of the FN. The increased incidence during
pregnancy supports this theory.8 Murai demonstrated that
the mean cross-sectional area of the labyrinthine and horizon-
tal segments of the canal were significantly smaller on the
affected side of patients with BP compared with the contra-
lateral side on computed tomography.13,14Infectious
RHS is a severe complication of VZV reactivation in the
geniculate ganglion and is the most common confirmed
infective cause for FNP. The classic triad consists of otalgia,
vesicles in the auditory canal and ipsilateral FNP.14
Borrelia burgdorferi, is a known cause of FNP in endemic
regions.1 Fifty percent of cases of BP in children younger than
10 years old are due to Lyme disease.3 Presumptive diagnosis
should be made in patients presenting with FNP associated
with induration and erythema of the face, particularly in the
summer.
FNP can be the first sign of AIDS, but is generally
described in chronic HIV infection.9Traumatic/Iatrogenic
Both blunt and penetrating cranio-facial trauma may cause
FN injuries.8 Road traffic accidents are the leading cause of
temporal bone’s fractures and in 31% of cases originates
injury to the FN.2 The FN may be mobilized, manipulated
or even sacrificed in craniofacial tumor removal, such as
acoustic neuromas. Rinaldi (2012) reported a 38.7%
incidence of postoperative facial nerve deficit after acoustic
neuroma surgery, besides anatomical preservation of the
FN.15 Total ipsilateral facial weakness, decreased tearing,
hyperacusis, associated defects with V, VI, VIII, and Horner
syndrome occur classically post-surgery of tumors in the
cerebellopontine angle.8 According to Hohman (2014), the
most common operation resulting in FN injury was
temporomandibular joint replacement.6Neoplastic
FNP may result from tumors themselves, either through
direct compression, significant stretching or infiltration of
the nerve. Cerebellopontine angle lesions may cause multiple
cranial nerve defects or affect the CN VII in isolation. Mat-
thies and Samii found that up to 17% of patients with acoustic
neuroma had signs of FN dysfunction prior to tumor
resection.1,16
FNP is the most frequent neurological presentation of sar-
coidosis. There is usually a bilateral, asymmetric involvement
of the parotid gland.17,18Clinical presentation (Table 1)
Idiopathic
BP typically presents with sudden and rapid onset of uni-
lateral facial weakness, often within a few hours. Sixty percent
of patients report preceding viral illness. The motor deficit is
almost always unilateral, with both the upper and lower parts
of the face affected.3 There is often drooping of the eyebrow,
corner of the mouth and loss of the ipsilateral nasolabial fold.
It is an isolated mononeuropathy and the association with
other CN palsies should alert the examiner to other causes.
Bell’s phenomenon or the upward movement of the eye
on attempted closure of the lid due to weakness of the orbic-
ularis oculi is usually present.3
Maximal weakness presents after 2 days and resolution in
3–4 weeks. Patients may also complain of ipsilateral earache,
numbness of the face, tongue and ear.3 Cases of hyperacusis,
tinnitus, taste disturbances and decreased lacrimation have
also been reported.3Ramsay–Hunt syndrome
RHS is a clinical diagnosis based on unilateral facial weak-
ness plus vesicular lesions in the ipsilateral ear, hard palate or
anterior 2/3 of the tongue. Otalgia or vertigo complete the
triad. Lesions are not required for diagnosis and around 2–
35% of unilateral FNP without vesicles are actually herpes
zoster sine herpete.4 Murakami observed that auricular vesi-
cles appeared before (19.3%), during (46.5%), or after
(34.2%) the onset of FNP.19
Zoster patients (88%) have a high incidence of complete
paralysis and have a more severe painful paralysis associated
with vestibulocochlear symptoms at onset.
Figure 1. Central FNP due to ischemic vascular stroke. Only the lower part of the left face is affected.
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Initial evaluation should include accurate clinical history,1
followed by a comprehensive examination,2 establishing
whether the FNP is acute or chronic, unilateral or bilateral,
exclude secondary causes and differentiate between proxi-
mal and distal lesions.
Clinical history
The clinician should inquire about underlying medical
problems that could predispose to FNP, such as prior stroke,
brain tumors, skin cancers of the head or face, parotid
tumors, facial/head trauma, or recent infections.
Symptoms such as dizziness, dysphagia, or diplopia sug-
gest a diagnosis other than BP.
The timing of onset remains important. Symptoms associ-
ated with neoplastic or infectious causes of FNP often pro-
gress gradually.20
Recurrence of FNP occurs in BP, tumors and Melkersson–
Rosenthal syndrome. Alternating side of the recurrence is
seen more with BP and ipsilateral recurrence implies tumor
until proven otherwise.9
Physical examination
A thorough examination of the head and neck, including
ophthalmological, otological, oral and neurological examina-
tion should be performed.
Ophthalmologic examination
Baseline visual acuity, pupillary reactions, Schirmer’s test
(if pathological, it locates the impairment upstream from
the origin of the great superficial petrosal nerve or along its
path) and optic disc evaluation.1Evaluation of sensitivity of the cornea: absence of ipsilat-
eral corneal reflex is an early sign of cerebellopontine angle
syndrome.
Otological examination (including otoscopy)
Parotid swelling may suggest a malignant or inflammatory
mass. Vesicles around the ear suggest RHS. Inflammation or
pus from the ear may indicate malignant otitis externa. Ten-
derness of the mastoid may suggest infection spreading from
the middle ear.
Oral examination
The sensation of taste of the anterior two-thirds of the
tongue and the function of salivary glands are not fre-
quently tested. Ask the patient about it or place small
amounts of sugar, salt, vinegar and quinine for the
evaluation.
Neurologic examination
Assessment of all cranial nerves
Ocular movements: ipsilateral VI nerve palsy may suggest
a pontine lesion.
Evaluation of FN includes inspection of the face at rest,
during speech, voluntary, emotional and involuntary move-
ments with characterization of the overall movement of the
face, the extent of the facial weakness and the involvement
of all nerve branches.
Inspection at rest
Evaluate the upper eyelid retraction, the blink reflex and
the paralytic ectropion.
Figure 2. Peripheral right FNP with both upper (absence of frontal wrinkles) and lower parts of the face affected. The picture shows lagophthalmos with
medial canthal paralytic ectropion. Bell’s phenomenon is present.
Figure 3. Testing for Bell’s phenomenon in a patient with FNP after
acoustic neuroma resection.
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Ask the patient to wrinkle the eyebrows. Evaluate the eye-
brow position and elevation. In central palsy the frontalis is
spared, whereas in peripheral palsy, upper and lower por-
tions of the face are affected (Figs. 1 and 2).
Ask the patient to show the teeth. If a lesion of the FN is
present on one side, the mouth is distorted. A greater area
of the teeth is revealed on the side of the intact nerve (Fig. 1).
Raise the patient’s eyelids while asking to close the eyes. If
the orbicularis oculi is paralyzed, the eyelid on that side is
easily raised. Look for Bell’s phenomenon (Fig. 3).
Evaluate the lagophthalmos on gentle and forced closure
(Fig. 2).
The House–Brackmann (HS) grading system (Table 2)
helps to document the degree of FNP and to predict recov-
ery. It is the most widely used and accepted.Laboratory testing
Clinicians should not obtain routine laboratory testing in
patients with new-onset BP. However, it may be indicated
in patients with identifiable risk factors or atypical presenta-
tion. In endemic areas, Lyme disease serology should be
considered.20Diagnostic imaging
Imaging is not systematic with peripheral FNP, although it
is with central FNP.10,19 Almost all patients with BP regain
some function within 3 months of onset. Any case without
resolution within 4 months should undergo contrast-
enhanced imaging of the parotid gland, temporal bone and
brain. Repeat imaging is indicated if symptoms persist at
7 months without a readily identifiable cause. Biopsy of the
affected tissue adjacent to the FN may be considered if imag-ing is negative at 7 months.3 Imaging is needed if there is
progression or recurrence of BP or if there is association with
other CN palsies.10Management
Many factors are involved in the treatment decision-mak-
ing process of patients with FNP: the underlying cause,
expected duration of nerve dysfunction, anatomical manifes-
tations, severity of symptoms and objective clinical
findings.14Steroids and acyclovir
Nerve conduction does not become abnormal until 3 days
after the onset of paresis when nerve degeneration develops.
The goal of medical therapy is to treat patients within this
3-day window.1
Updated Guidelines of the American Academy of Neurol-
ogy (AAN) state that systemic steroids should be offered to
Table 2. House–Brackmann grading system.
Grade Description Characteristics
I Normal Normal facial function
II Mild dysfunction Gross: slight weakness noticeable on close inspection, may have very slight synkinesis. At rest: normal symmetry
and tone. Motion: forehead- moderate to good function, eye-complete closure with minimum effort, mouth-
slight asymmetry
III Moderate dysfunction Gross: obvious but not disfiguring difference between the two sides; contracture and/or hemifacial spasm. At
rest: normal asymmetry and tone. Motion: forehead- slight to moderate movement; eye- complete closure with
effort; mouth- slightly weak with maximum effort
IV Moderately severe
dysfunction
Gross: obvious weakness and/or disfiguring asymmetry. At rest: normal asymmetry and tone. Motion: forehead-
none; eye- incomplete closure; mouth: asymmetric with maximum effort
V Severe dysfunction Gross: only barely perceptible motion. At rest: asymmetry. Motion: forehead-none; eye- incomplete closure;
mouth- slight movement
VI Total paralysis No movement
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recovery (Level A recommendation).21 A recent Cochrane
review found that only 23% of patients treated with cortico-
steroids had incomplete recovery of facial motor function at
6 months, compared to 33% of patients treated with pla-
cebo.22 In addition, patients receiving corticosteroids had a
significant reduction in motor synkinesis.3,22
HSV infection is believed to be the main cause of BP; it
would then be reasonable to include acyclovir in its treat-
ment.1 However, a Cochrane systematic review concluded
that antivirals provide no significant benefit over placebo in
generating complete recovery from BP.23 According to the
AAN, patients with new-onset BP, might be offered antivirals
(in addition to steroids) (Level C), because of the possibility of
modest increase in recovery.21
In RHS, a Cochrane review of the sole randomized con-
trolled trial comparing combined treatment to corticoste-
roids alone showed no significant difference in outcomes.24
The largest RHS treatment study was a retrospective analysis
of 80 cases. Patients treated with acyclovir–prednisone within
72-h of symptoms onset had a complete recovery rate of 75%
vs 30% of patients treated after 7 days. Early administration
also reduced nerve degeneration.4,25 Acyclovir 800 mg
5 times daily or 1 g valacyclovir TID for 7–10 days plus pred-
nisone 1 mg/kg for 5 days and taper was used in published
trials.4
Surgery for FN decompression
Surgical decompression remains highly controversial due
to its risks and should be considered in refractory cases.3
There is some evidence in favor of surgical decompression
with documented loss of >90% of axonal fibers on the elec-
troneurography prior to day 14 of weakness onset.1,26 Hato
et al. decompressed the tympanic and mastoid segments
of the canal with concurrent placement of basic fibroblast
growth factor impregnated biodegradable gelatin hydrogel
around the nerve. The rate of complete recovery was 75%
compared to 44.8% by the conventional decompression
method and 23.3% on the steroids alone.14
Corneal exposure and lagophthalmos
On FNP patients, the cornea is especially at risk because
of improper lid closure due to lagophthalmos and paralytic
ectropion and due to decreased tear production and
distribution of the tear film. Some works also demonstrated
increased meibomian gland dysfunction.27,28Treatment directed at protecting the cornea depends on
the degree of nerve lesion and of the risk of corneal damage
based on the amount of lagophthalmos, the quality of Bell’s
phenomenon and the presence or absence of paralytic ectro-
pion.8,9 Furthermore, corneal sensation testing should be
performed, as patients with both V and VII palsies are at
increased risk of developing corneal decompensation.29 Neu-
rotrophic corneal epithelium is more prone to injury, heals
poorly and patients may be unaware of the corneal damage.
The goals of therapy are to protect the cornea and to
restore the blink response using minimal intervention and
maintaining good visual acuity.1Temporary treatment
If recovery is expected, less invasive techniques should be
employed.
When there is low corneal risk and good prognosis for
recovery, intensive lubricants and taping the lid with a stiff
tape overnight will usually be enough.8 Preservative-free
teardrops during the day and a more viscous ointment over-
night may be used. Moisture chambers act as barriers to
evaporation.9
Scleral contact lenses were recently described as a valid
alternative to tarsorrhaphy for patients with corneal exposure
and anesthesia, providing effective protection in an estheti-
cally acceptable way and optimizing visual function.30,31
Botulinum toxin injection induces ptosis by temporarily
paralyzing the levator palpebrae superioris and thus protect-
ing the cornea. It is an excellent low-risk temporary (effect
sustained for a mean of 46 days) alternative for postoperative
high grade FNP, when the FN is anatomically intact.32 In 16 of
21 patients further surgical intervention was avoided and cor-
neal healing was obtained. Significant improvement in cor-
neal symptoms and decreased use of artificial tears was
also reported.14 However, it affects patients’ vision and may
provide less than adequate protection as the levator function
returns.8,9
Temporary tarsorrhaphy can be achieved with a simple
suture or cyanoacrylate glue. The classic central tarsorrhaphy
is cosmetically and visually poor, but gives good protection.
Lateral tarsorrhaphy may not adequately close the eye, par-
ticularly if there is significant lower lid ectropion.8
External eyelid weights have similar design to those for
implantation and are fixed to the pretarsal skin surface with
double-sided hypoallergenic adhesive tape.9
Figure 4. Gold weight trial procedure. Gold weight reduction of the lagophthalmos, without inducing significant upper eyelid ptosis in the primary
position.
Figure 5. Upper eyelid load gold weight combined with lateral tarsorrhaphy. Complete eyelid closure was achieved, without inducing significant ptosis.
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be satisfactorily managed with lubricants or have decreased
tear production.9Permanent treatment
When no recover of nerve function is expected, the long-
term protection of the cornea is more complex and depends
on the degree and manner in which the upper and lower lids
are affected. The palpebral aperture can be closed in four
ways: (1) by lowering the upper eyelid, (2) raising the lower
eyelid, (3) medial and (4) lateral closure.
(1) An upper eyelid load weight provides passive lid clo-
sure and increased blink response, along with lowering of
the retracted upper eyelid. It has been shown to significantly
reduce lagophthalmos, improve corneal coverage and
decrease lubricant-dependence. Lid loading with 99.9% pure
gold is the most commonly performed surgery for FNP of any
etiology.8 It is quite simple to place, has a very low complica-
tion rate,29 is equally effective in early and later stages and if
the nerve function improves it is easy to remove.8 Advanta-
ges over tarsorrhaphy are better cosmesis and maintenance
of binocular visual field. The standard gold weights range
from 0.6 g to 1.6 g in 0.2 g increments. The success of gold
weight implantation depends on accurate prediction of the
ideal gold weight for a given patient. Serial increments of trial
gold weights are pasted to the pretarsal upper eyelid skin to
assess the expected postoperative outcome (Fig. 4). An ideal
weight would be one that achieves adequate reduction of the
lagophthalmos without inducing significant ptosis. Hontanilla
(2001) suggested a correction factor of 0.2 g to be added tothe final weight before lid loading.33 Aggarwal (2007)
assessed the accuracy of the gold weight trial procedure in
predicting the postoperative eyelid closure and concluded
that it led to a 30% undercorrection and that a higher correc-
tion factor should be considered for patients with preopera-
tive lagophthalmos higher than 8 mm.34 Thin-profile platinum
weights can be an alternative to the gold.35 (Fig. 5).
An alternative to the gold weight implant is the less fre-
quently used palpebral spring. This is the most commonly
used method of dynamic eyelid animation. A custom-made
stainless steel spring is implanted and secured to the superior
orbital rim and pretarsal area. When the levator relaxes as the
opposite eye closes, the spring actively pushes the eyelid
down. The spring allows for a more rapid eyelid excursion
and complete closure compared to gold weights and helps
to restore corneal squeegee effect. However, erosion is a
common problem that may require frequent adjustments.36
Upper eyelid retraction is common sequelae of FNP due
to the unopposed action of the levator and to thixotropy
(crossbridge formations between actin and myosin filaments
causing stiffness of the levator muscle).8 This should be
addressed prior to considering lid loading. The choice of
the procedure depends on the amount of retraction: muller-
ectomy is sufficient to treat 1–3 mm of retraction, but with
larger amounts retractor recession transconjunctivally or with
an anterior approach with or without a spacer material may
be required.8
(2) When addressing problems of the lower eyelid, the
choice of surgical procedure will depend on the degree of
laxity or ectropion and state of the medial and lateral canthal
tendons. Increased support to raise the lower lid can be
achieved by combining medial and lateral canthoplasties.
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bined with insertion of a spacer. In cases of marked tissue
atrophy, an autogenous fascial sling can be threaded ham-
mock-like through the entire length of the lid, anchored by
fixation to the medial canthal tendon and lateral orbital
periosteum.8.
(3) The medial palpebral aperture closure depends on the
laxity of the medial canthal tendon. A punctual ectropion can
be treated with a medial canthoplasty or a medial tarsal strip.
Where there is significant tendon laxity, a deep periosteal
Royce-Johnston suture or medial wedge excision could be
used.
(4) Permanent lateral tarsorraphy has largely been super-
seded by the lateral canthal sling.8. It has the advantage that
it can be augmented by inserting the strip higher on the rim
to assist in tear drainage or combining it with a small lateral
tarsorraphy if the horizontal aperture needs to be
shortened.8
Dynamic correction of paralytic lagophthalmos frequently
involves transfer of the temporalis muscle, which is effective
and can provide strong eyelid closure over and for an
extended period of time. Reanimation of paralyzed muscles
using adjacent motor nerves has also been attempted: Hay-
ashi performed an hypoglossal-facial nerve anastomosis with
excellent success rates37; Corrales used hypoglossal-facial
nerve anastomosis to treat patients with central FNP with
comparable success with those for peripheral dysfunction38
and the masseter nerve can also be utilized.13
The use of permanent tarsorrhaphy has decreased since
other rehabilitation procedures arise. It is most suited to
cases with corneal sensory deficits. Despite being cosmeti-
cally and visually poor, for patients in whom medical therapy
is difficult and lacrimal gland function is lost, it remains an
important treatment option.Other modalities of therapy
No evidence supports significant benefit from physical
therapy or acupuncture for BP. Hyperbaric oxygen therapy
might be effective on moderate to severe BP.39–41Prognosis
Spontaneous, complete recovery of BP occurs in up to
70% of cases. Usually remission begins within 3–4 weeks, with
complete recovery within 6 months. Peitersen found that, in
2570 cases of peripheral FNP, 85% of patients’ function
was returned within 3 weeks and in the remaining 15% after
3–5 months. In 71% normal mimical function was obtained,Table 3. Negative prognostic factors that influence outcome in Bell’s palsy.
Prognostic factor Value
Pain or altered taste No evidence
Complete paralysis Strong evidence
Age >60 years-old Strong evidence
Minimal recovery by 3-weeks Strong evidence






Hypertension Some evidencesequelae were slight in 12%, mild in 13% and severe in 4%
of patients. Contracture and synkinesis was found in 17%
and 16% of patients respectively.
Patients presenting with incomplete paresis show 93–98%
of spontaneous complete recovery. Some factors that influ-
ence prognostic outcome in BP are shown in (Table 3). The
recurrence rate of BP is about 12% of cases but multiple
recurrences are rare.3
RHS has a less favorable recovery profile than BP: 21%
return to normal function and 79% develop sequelae, 54%
with poor recovery.
FNP after surgery: Pelaz (2008) evaluated the recovery to
normal function after complete FNP secondary to acoustic
neuroma surgery and found that only 16.6% achieved HB
grade I. The majority presented HB grade III (33.3%) or IV
(26.6%). Poor recovery was associated with a tumor size big-
ger than 2 cm, males, age >65 years and lesions resected by
the translabyrinthine approach.42 Rinaldi (2012) reported a
long-term facial deficit after surgery of 37.1%.15Complications, sequelae, synkinesis
Long-term complications can develop from BP. Yamamoto
observed sequelae in 9.1%43; Kawai described an incidence
of 19%44 and Peitersen reported 29%.1,5 It is more common
in complete or nearly complete FNP.
When nerve fibers are damaged they may aberrantly
regenerate. During regeneration, excessive collateral branch-
ing of the axons occur, not only at the site of the lesion but
also along the entire course of the nerve. These extra-axons
may contribute to the abnormal location of the regenerated
axon in the facial nucleus and results in synkinesis. Hyperex-
citability and ephaptic phenomenon were also implicated.1
This can result in lacrimation while eating or crocodile tears
(aberrant connections with the lacrimal ducts instead of the
salivary glands) or involuntary uncoordinated muscle move-
ment associated with voluntary movement of the muscle
when regenerating motor neurons innervate inappropriate
muscles.3 Rarely, aberrant innervation may result between
two adjacent cranial nerves such as facial-trigeminal and
facial-oculomotor synkinesis.1
These abnormal movements can be more distressing than
the FNP itself.1 Botulinum toxin injection and facial reanima-
tion are among the proposed methods of treatment.Conflict of interest
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